Sriram Ryali
Finanzdirektor/CFO bei CODEXIS, INC.
Vermögen: 170 769 $ am 30.04.2024
Profil
Sriram Ryali is currently the Chief Financial & Accounting Officer at Codexis, Inc. Prior to his current position, he held various roles including Senior Director-Financial Planning & Analysis at Jazz Pharmaceuticals Plc, Vice President-Finance at Aimmune Therapeutics, Inc., Chief Financial Officer at Eiger BioPharmaceuticals, Inc., and Head-Medical Affairs, Technical Operations, R&D at Onyx Pharmaceuticals, Inc. Mr. Ryali completed his undergraduate degree at the University of California, Los Angeles and holds an MBA from UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CODEXIS, INC.
0,09% | 18.04.2024 | 64 441 ( 0,09% ) | 170 769 $ | 30.04.2024 |
Aktive Positionen von Sriram Ryali
| Unternehmen | Position | Beginn |
|---|---|---|
| CODEXIS, INC. | Finanzdirektor/CFO | 23.01.2023 |
Ehemalige bekannte Positionen von Sriram Ryali
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Finanzdirektor/CFO | 20.01.2023 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Ausbildung von Sriram Ryali
| University of California, Los Angeles | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| CODEXIS, INC. | Process Industries |
| Private Unternehmen | 2 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
